These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9178823

  • 1. Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4.
    Gold DV, Cardillo T, Vardi Y, Blumenthal R.
    Int J Cancer; 1997 May 16; 71(4):660-7. PubMed ID: 9178823
    [Abstract] [Full Text] [Related]

  • 2. Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer.
    Alisauskus R, Wong GY, Gold DV.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5743s-5748s. PubMed ID: 7493339
    [Abstract] [Full Text] [Related]

  • 3. Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.
    Yamamoto A, Sawada T, Yamashita Y, Nishihara T, Ho JJ, Kim Y, Chung KH.
    Oncol Rep; 1999 Dec 01; 6(1):179-84. PubMed ID: 9864424
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer.
    Cardillo TM, Ying Z, Gold DV.
    Clin Cancer Res; 2001 Oct 01; 7(10):3186-92. PubMed ID: 11595713
    [Abstract] [Full Text] [Related]

  • 5. Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4.
    Gold DV, Alisauskas R, Sharkey RM.
    Cancer Res; 1995 Mar 01; 55(5):1105-10. PubMed ID: 7866995
    [Abstract] [Full Text] [Related]

  • 6. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
    Stein R, Juweid M, Mattes MJ, Goldenberg DM.
    Cancer Biother Radiopharm; 1999 Feb 01; 14(1):37-47. PubMed ID: 10850286
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer.
    Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5857s-5863s. PubMed ID: 7493360
    [Abstract] [Full Text] [Related]

  • 8. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 9. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 10. Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas.
    Peterson JA, Blank EW, Ceriani RL.
    Cancer Res; 1997 Mar 15; 57(6):1103-8. PubMed ID: 9067279
    [Abstract] [Full Text] [Related]

  • 11. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
    Buchsbaum DJ, Lawrence TS, Roberson PL, Heidorn DB, Ten Haken RK, Steplewski Z.
    Int J Radiat Oncol Biol Phys; 1993 Mar 15; 25(4):629-38. PubMed ID: 8454481
    [Abstract] [Full Text] [Related]

  • 12. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 13. Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
    Stein R, Chen S, Haim S, Goldenberg DM.
    Cancer; 1997 Dec 15; 80(12 Suppl):2636-41. PubMed ID: 9406718
    [Abstract] [Full Text] [Related]

  • 14. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.
    Stein R, Goldenberg DM, Thorpe SR, Mattes MJ.
    J Nucl Med; 1997 Mar 15; 38(3):391-5. PubMed ID: 9074526
    [Abstract] [Full Text] [Related]

  • 15. Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel.
    Govindan SV, Stein R, Qu Z, Chen S, Andrews P, Ma H, Hansen HJ, Griffiths GL, Horak ID, Goldenberg DM.
    Breast Cancer Res Treat; 2004 Mar 15; 84(2):173-82. PubMed ID: 14999147
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W.
    Int J Cancer; 1998 May 29; 76(5):738-48. PubMed ID: 9610734
    [Abstract] [Full Text] [Related]

  • 17. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM, Wulst E, Radetzky S, Blumenthal RD, Dunn RM, Gratz S, Rave-Fränk M, Schmidberger H, Raue F, Becker W.
    Cancer Res; 1997 Dec 01; 57(23):5309-19. PubMed ID: 9393755
    [Abstract] [Full Text] [Related]

  • 18. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
    Lee Y, Bullard DE, Humphrey PA, Colapinto EV, Friedman HS, Zalutsky MR, Coleman RE, Bigner DD.
    Cancer Res; 1988 May 15; 48(10):2904-10. PubMed ID: 2452014
    [Abstract] [Full Text] [Related]

  • 19. Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer.
    Gold DV, Schutsky K, Modrak D, Cardillo TM.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3929S-37S. PubMed ID: 14506191
    [Abstract] [Full Text] [Related]

  • 20. [Immunoscintigraphy and radioimmunotherapy of transplanted pancreatic carcinoma. Experimental animal studies with 131I-labeled monoclonal antibodies against CA 19-9, CEA and CA 125].
    Klapdor R, Montz R, Greten H, Chatal JF, Douillard JY, Saccavini JC, Dietel M.
    Nuklearmedizin; 1985 Dec 01; 24(5-6):227-31. PubMed ID: 3867855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.